Literature DB >> 2793170

Sublocalization of von Willebrand factor pseudogene to 22q11.22-q11.23 by in situ hybridization in a 46,X,t(X;22)(pter;q11.21) translocation.

P Patracchini1, E Calzolari, V Aiello, P Palazzi, P Banin, G Marchetti, F Bernardi.   

Abstract

The von Willebrand factor pseudogene, previously mapped to chromosome 22, was sublocalized by in situ hybridization using as probe a von Willebrand factor cDNA fragment completely contained in the pseudogenic region. Chromosome spreads were from a patient carrying a unique balanced de novo translocation 46,X,t(X;22)(pter;q11.21). Silver grain analysis indicated that the human von Willebrand factor pseudogene is located on 22q,11,22-q11,23, a region relevant for several somatic and constitutional chromosomal alterations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793170     DOI: 10.1007/bf00285168

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  30 in total

1.  Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.

Authors:  B R Seizinger; R L Martuza; J F Gusella
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

2.  A high resolution in situ hybridization technique for the direct visualization of labeled G-banded early metaphase and prophase chromosomes.

Authors:  M E Chandler; J J Yunis
Journal:  Cytogenet Cell Genet       Date:  1978

3.  Report of the committee on the genetic constitution of chromosome 22.

Authors:  J C Kaplan; B Emanuel
Journal:  Cytogenet Cell Genet       Date:  1988

4.  Gene deletions correlate with the development of alloantibodies in von Willebrand disease.

Authors:  B B Shelton-Inloes; F F Chehab; P M Mannucci; A B Federici; J E Sadler
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  X-autosome translocations: cytogenetic characteristics and their consequences.

Authors:  M G Mattei; J F Mattei; S Ayme; F Giraud
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

Authors:  D Ginsburg; R I Handin; D T Bonthron; T A Donlon; G A Bruns; S A Latt; S H Orkin
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

7.  Molecular analysis of both translocation products of a Philadelphia-positive CML patient.

Authors:  A de Klein; T van Agthoven; C Groffen; N Heisterkamp; J Groffen; G Grosveld
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

8.  De novo complex autosomal translocation involving chromosomes 8, 13 and 15 in a girl with a sporadic retinoblastoma.

Authors:  E Calzolari; P Palazzi; V Aiello; E Mazzeo; P Perri; A Minelli; L del Senno; P Patracchini; F Bernardi
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

9.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

10.  Von Willebrand factor in the vessel wall mediates platelet adherence.

Authors:  H V Stel; K S Sakariassen; P G de Groot; J A van Mourik; J J Sixma
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

View more
  4 in total

1.  Characterization and mapping of the 5' portion of von Willebrand factor pseudogene.

Authors:  P Patracchini; G Marchetti; V Aiello; G Croci; E Calzolari; F Bernardi
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

Review 2.  Role of von Willebrand factor in the haemostasis.

Authors:  Flora Peyvandi; Isabella Garagiola; Luciano Baronciani
Journal:  Blood Transfus       Date:  2011-05       Impact factor: 3.443

Review 3.  Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features.

Authors:  T Ogata; N Matsuo
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

4.  Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.

Authors:  Priyanka Kasatkar; Shrimati Shetty; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.